Benjamin Vandendriessche, PhD, Chief Executive Officer of the Digital Medicine Society (DiMe)
The Medical Affairs Professional Society’s Technology and Innovation Symposium on October 15 will feature a keynote from Digital Medicine Society CEO Benjamin Vandendriessche.
AI is changing what physicians, payers, and patients expect from Medical Affairs, and the profession has a real opportunity to lead that change.”— Travis Hege, CEO of MAPSBOSTON, MA, UNITED STATES, October 2, 2026 /EINPresswire.com/ — With artificial intelligence transitioning from experimental phases into routine operations throughout the life sciences sector, the Medical Affairs Professional Society (MAPS) is gathering leaders from pharmaceutical, biotechnology, and medical technology fields for the 2026 Medical Affairs Technology and Innovation Symposium on Thursday, October 15, at One Boston Place in downtown Boston. REGISTRATION IS NOW OPEN.
Organized by the MAPS New England Chapter and backed by sponsors Indegene and ACTO, this symposium will delve into how Medical Affairs teams can utilize AI, digital health, and data science to boost value for physicians, patients, and their companies—while doing so in a responsible manner.
"AI is changing what physicians, payers, and patients expect from Medical Affairs, and the profession has a real opportunity to lead that change," says Travis Hege, CEO of MAPS. “This symposium brings together the people who are already putting these tools to work, so attendees leave with practical insight they can apply right away."
The event starts with a keynote address by Benjamin Vandendriessche, PhD, Chief Executive Officer of the Digital Medicine Society (DiMe), entitled "Realizing the Promise of Digital Health: From Innovation to the Sustainable Transformation of Medicine."
Two Expert Panels on AI in Medical Affairs:
– From Promise to Performance: AI at Scale in Medical Affairs investigates the steps required to move AI beyond pilot stages and embed it into daily workflows.
– Leading into the Future: Ethical Use Cases for AI and Data Science in Medical Affairs tackles the governance, transparency, and ethical dilemmas confronting every Medical Affairs leader today.
Featured Panelists:
– Elnaz Alipour, Senior Director, Medical Analytics, Pfizer
– Gary Fanjiang, VP, US Medical Affairs, Amgen
– Lee Gervitz, Senior VP, Medical Affairs, Xenon Pharmaceuticals
– Parth Khanna, CEO and Founder, ACTO
– Jully Kim, Senior Director, Global Medical Operations, CSL
– Antonia Panayi, Head of Global Medical Evidence, Takeda
– Gem Roy, Associate Director, AI Enablement, Merck
The day wraps up with a networking reception, offering attendees the chance to interact with speakers and colleagues from across Boston’s life sciences community.
Event Details:
– Date: Thursday, October 15, 2026
– Time: 12:30 – 7:30 PM ET
– Location: One Boston Place, 201 Washington Street, Boston, MA 02108
Open to MAPS members and non-members, with discounted rates for students.
About the Medical Affairs Professional Society (MAPS)
Established in 2016, the Medical Affairs Professional Society (MAPS) is a 501(c)(3) nonprofit organization and the worldwide authority for Medical Affairs professionals, linking more than 18,000 members globally across pharmaceuticals, biotech, MedTech, and related organizations. MAPS supports professionals at every career stage—from newcomers to senior executives—through top-tier education, research-backed insights, expert-led gatherings, and a global network devoted to advancing the discipline and shaping its future. Find out more at MedicalAffairs.org.
Craig Ruvere
Medical Affairs Professional Society
cruvere@medicalaffairs.org
Visit us on social media:
LinkedIn
YouTube
Also worth a look: Mitolyn, Built Around the Purple Peel Exploit, has been Launched, Designed to Enhance Mitochondrial Health & Manage Weight and Out Today: “My Favorite Things” by Award-winning Vocalist Nicole Henry.
